Connection

Julian Schulze Zur Wiesch to Hepatitis C, Chronic

Back to Details
This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about Hepatitis C, Chronic.
Julian Schulze Zur Wiesch
Connection Strength
0.524
Hepatitis C, Chronic
  1. Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03). J Med Virol. 2018 02; 90(2):304-312.
    View in: PubMed
    Score: 0.355
  2. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort. Med Microbiol Immunol. 2017 Oct; 206(5):379-382.
    View in: PubMed
    Score: 0.087
  3. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). Clin Infect Dis. 2016 11 15; 63(10):1320-1324.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.